The pectin-calcium chloride matrix tablets had different release profile in various media.
果胶氯化钙骨架片在不同的释放介质中表现出不同的释放行为。
METHODS Wet granulation technique was employed to prepare pectin-calcium chloride matrix tablets.
方法湿法制粒压片法制备吲哚美辛果胶氯化钙骨架片。
Objective: to study the factors influencing the release mechanism of rutin from sustained release matrix tablets.
目的：考察芦丁缓释骨架片释药机制的影响因素。
OBJECTIVE To prepare the controlled-release matrix tablets with ideal properties by quantitatively controlled method.
目的对压片工艺进行定量化控制，以制备出理想性能的阿司匹林控释片剂。
METHODS Experiments were arranged using uniform design method. Aspirin controlled-release matrix tablets were prepared.
方法用均匀设计法设计试验，制备阿司匹林控释骨架片。
The system of multi-layered matrix tablets provided an effective method for zero-order release of highly soluble drugs.
因此，多层骨架片系统是制备高水溶性药物控释制剂的有效方法。
Objective To study the influential factors of the release rate of neogambogic acid from sustained release matrix tablets.
目的研究新藤黄酸骨架片体外释药速率的影响因素。
A few of evaluation methods for drug release in vitro of sustained-controlled matrix tablets were introduced in this review.
本文简要介绍了几种缓控释骨架片药物体外释放行为的评价方法。
ObjectiveTo make Singopicroside hydrophilic gel matrix tablets and to examine the factors affecting their dissolution rates.
目的制备丁香苦苷亲水凝胶骨架片，并对其释药影响因素进行了研究。
OBJECTIVE: to make diclofenac sodium (DCF) hydrophilic matrix tablets and examine the factors affecting their dissolution rates.
目的：制备双氯芬酸钠(DCF)亲水凝胶骨架片，并对其释药影响因素进行了研究。
OBJECTIVE: To study the relaxation of in situ crosslinking degree induced by calcium cations in the pectin-based matrix tablets.
目的：研究钙离子诱导的果胶分子在体交联度松弛的机理。
MethodsWith HPMC as the matrix, the Singopicroside hydrophilic matrix tablets were prepared by a wet granulation compression method.
方法采用羟丙甲基纤维素hpmc为骨架材料，以湿法制粒压片法制备丁香苦苷亲水凝胶骨架片。
Aspirin controlled release matrix tablets were prepared using quantitative controlling method of high speed stirring granulation technology.
用均匀设计法设计试验，对高速搅拌制粒工艺进行定量化控制，制备了阿司匹林控释骨架片。
Result the sorts, model and amounts of matrix materials had remarkable influence on the release mechanism of sulindac from the matrix tablets, while the influence of the selected fillers was marginal.
结果骨架材料的种类、型号及用量对舒林酸释放机制影响较大，填充剂对舒林酸释放有一定影响。
OBJECTIVE Breviscapine sustained-release tablets(BST)were formulated with hydroxypropyl-methylcellulose as the matrix material and the release mechanism of the tablets was studied.
目的以羟丙甲基纤维素为骨架材料制得灯盏花素缓释片，并对释药机制进行探讨。
Method: GBE sustained-release tablets were prepared by direct compression method using sodium carboxymethylcellulose CMC-Na and hydroxypropyl methylcellulose HPMC as matrix excipients.
方法：以溶胀性材料羧甲基纤维素钠和羟丙甲基纤维素为骨架材料，直接粉末压片制备银杏提取物缓释片。
CONCLUSION: the controlled release film-coated technique and the matrix technique can be used to prepare controlled release tablets for highly hydrophilic drugs.
结论：采用控释薄膜包衣技术和骨架控释技术可用于制备强水溶性药物控释制剂。
The invention relates to an extended-release matrix formulation capable of being directly compressed into tablets comprising niacin, a release-retarding agent, and other excipients.
本发明涉及能够被直接压成片剂的缓释骨架制剂，所述片剂包含烟酸、延迟释放剂和其它赋形剂。
The phase transition, barrier function and front movement of the gel layer are closely related to drug release process of hydrophlic gel matrix sustained-release tablets.
亲水凝胶骨架缓释片的释药过程与相转变过程、凝胶层屏障及区域前沿移动行为密切相关。
The phase transition, barrier function and front movement of the gel layer are closely related to drug release process of hydrophlic gel matrix sustained-release tablets.
亲水凝胶骨架缓释片的释药过程与相转变过程、凝胶层屏障及区域前沿移动行为密切相关。
应用推荐